Home › Funds › Renaissance Technologies › ALGS
Renaissance Technologies position in ALGS
ALIGOS THERAPEUTICS INC · Health Care
Latest position (Q2 2026)10.80K sh
Reported value held$62.32K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 53.20K | $825.00K | New |
| Q4 2021 | 54.50K | $647.00K | Add |
| Q1 2022 | 362.31K | $779.00K | Add |
| Q2 2022 | 903.10K | $1.09M | Add |
| Q3 2022 | 730.60K | $804.00K | Reduce |
| Q4 2022 | 532.26K | $507 | Reduce |
| Q1 2023 | 452.86K | $396 | Reduce |
| Q2 2023 | 430.56K | $418 | Reduce |
| Q3 2023 | 321.36K | $240 | Reduce |
| Q4 2023 | 489.96K | $325 | Add |
| Q1 2024 | 808.26K | $792 | Add |
| Q2 2024 | 768.84K | $269.09K | Reduce |
| Q3 2024 | 13.44K | $116.42K | Reduce |
| Q4 2024 | 11.44K | $455.89K | Reduce |
| Q1 2025 | 39.58K | $326.50K | Add |
| Q2 2025 | 52.54K | $378.84K | Add |
| Q3 2025 | 55.02K | $539.19K | Add |
| Q4 2025 | 85.44K | $796.34K | Add |
| Q1 2026 | 100.45K | $746.34K | Add |
| Q2 2026 | 10.80K | $62.32K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ALGS
- Vanguard Group 200.40K sh · $1.87M · Q4 2025
- Marshall Wace 246.58K sh · $1.42M · Q2 2026
- Hillhouse Capital (HHLR Advisors) 76.25K sh · $439.94K · Q2 2026
- D. E. Shaw & Co 66.46K sh · $383.49K · Q2 2026
- UBS Group AG 59.99K sh · $346.12K · Q2 2026
- Geode Capital Management 47.17K sh · $272.32K · Q2 2026
- BlackRock Inc 30.29K sh · $174.78K · Q2 2026
- Citigroup Inc 1.81K sh · $10.43K · Q2 2026
- JPMorgan Chase & Co 344 sh · $1.87K · Q2 2026
- Morgan Stanley 204 sh · $1.18K · Q2 2026
- Wells Fargo & Co 100 sh · $577 · Q2 2026